Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001558370-17-004137
Filing Date
2017-05-10
Accepted
2017-05-10 16:34:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 f424b3.htm 424B3 9920
2 GRAPHIC f424b3g001.jpg GRAPHIC 4655
  Complete submission text file 0001558370-17-004137.txt   17474
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-217296 | Film No.: 17830916
SIC: 2834 Pharmaceutical Preparations